» Articles » PMID: 1319717

Comparison of Early and Late Feline Immunodeficiency Virus Encephalopathies

Overview
Journal AIDS
Date 1992 Apr 1
PMID 1319717
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Design: The study of the early and late stages of encephalopathy following infection by the feline immunodeficiency virus (FIV) was carried out with laboratory and naturally infected cats.

Interventions: Animals infected experimentally were injected with three different isolates of the virus, administered either intracerebrally or intravenously, and sacrificed at 7 days, 1 and 6 months (intracerebral injection), and 2, 6 and 12 months (intravenous injection) post-inoculation, respectively.

Conclusions: General features of encephalopathy were found to be identical, regardless of the method of inoculation or the viral strain used. Moderate gliosis and glial nodules, sometimes associated with perivascular infiltrates and white matter pallor, were observed at 1 month (intracerebral injection) and 2 months (intravenous injection), and remained unchanged until 12 months post-inoculation. The fact that these initial stages are identical for intravenously and intracerebrally inoculated cats suggests that the virus enters the brain very quickly in intravenously infected animals. Encephalopathy in cats naturally infected with FIV only consisted of gliosis, glial nodules, white matter pallor, meningeal perivascular calcification and meningitis. These lesions were more frequent and more severe in the group coinfected with feline leukaemia virus and feline infectious peritonitis virus. Although multinucleated cells were rare, the strong similarities between HIV and simian immunodeficiency virus encephalopathies at comparable stages support the view that FIV infection may represent an interesting model for a physiopathological approach of HIV infection of the central nervous system.

Citing Articles

Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31.

Fogle J, Hudson L, Thomson A, Sherman B, Gruen M, Lacelles B J Neurovirol. 2021; 27(2):302-324.

PMID: 33661457 PMC: 9210987. DOI: 10.1007/s13365-021-00956-2.


Feline Immunodeficiency Virus Neuropathogenesis: A Model for HIV-Induced CNS Inflammation and Neurodegeneration.

Meeker R, Hudson L Vet Sci. 2017; 4(1).

PMID: 29056673 PMC: 5606611. DOI: 10.3390/vetsci4010014.


Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes.

Louboutin J, Strayer D Antioxidants (Basel). 2016; 3(4):770-97.

PMID: 26785240 PMC: 4665507. DOI: 10.3390/antiox3040770.


Interstitial lung disease associated with Equine Infectious Anemia Virus infection in horses.

Bolfa P, Nolf M, Cadore J, Catoi C, Archer F, Dolmazon C Vet Res. 2013; 44:113.

PMID: 24289102 PMC: 3879148. DOI: 10.1186/1297-9716-44-113.


Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Meeker R, Poulton W, Feng W, Hudson L, Longo F J Neuroimmune Pharmacol. 2011; 7(2):388-400.

PMID: 22161560 PMC: 3746485. DOI: 10.1007/s11481-011-9325-0.